Financhill
Buy
67

RLAY Quote, Financials, Valuation and Earnings

Last price:
$12.53
Seasonality move :
-7.62%
Day range:
$10.48 - $13.04
52-week range:
$1.78 - $13.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
163.01x
P/B ratio:
4.60x
Volume:
8.9M
Avg. volume:
2.8M
1-year change:
403.61%
Market cap:
$2.6B
Revenue:
$15.4M
EPS (TTM):
-$1.61

Earnings Data

Next earnings date for RLAY
May 04
2026
Most recent earnings per share
-$0.32
Beat by $0.08
(Feb 26/2026)
Consensus Estimate
-$0.40
(Feb 26/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RLAY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2026 Q2 $60K -- -- -$0.38 --
05/04/2026 Q1 $3.4M -- -- -$0.35 --
02/26/2026 Q4 $4.3M $7M -$0.32 -$0.40 $0.08
11/06/2025 Q3 $160K -- -$0.43 -$0.42 -$0.01
08/07/2025 Q2 $75K $677K -$0.41 -$0.47 $0.06
05/05/2025 Q1 $11.1K $7.7M -$0.46 -$0.48 $0.02
02/26/2025 Q4 $5.5M -- -$0.45 -$0.55 $0.09
11/06/2024 Q3 $80K -- -$0.63 -$0.78 $0.16
08/06/2024 Q2 $88.9K -- -$0.69 -$0.73 $0.03
05/02/2024 Q1 $109.1K $10M -$0.62 -$0.69 $0.07
02/22/2024 Q4 $610K -- -$0.67 -$0.77 $0.10
11/02/2023 Q3 -- $25.2M -$0.54 -- --
08/08/2023 Q2 -- $119K -$0.81 -- --
05/04/2023 Q1 -- $226K -$0.78 -- --
02/23/2023 Q4 -- $253K -$0.56 -- --
11/03/2022 Q3 -- $344K -$0.76 -- --
08/04/2022 Q2 -- $365K -$0.71 -- --
05/05/2022 Q1 -- $419K -$0.57 -- --
02/24/2022 Q4 -- $567K -$0.62 -- --
11/10/2021 Q3 -- $666K -$0.66 -- --
08/12/2021 Q2 -- $844K -$2.10 -- --
05/13/2021 Q1 -- $952K -$0.47 -- --
03/25/2021 Q4 -- $82.7M $0.39 -- --
11/12/2020 Q3 -- -- -$2.38 -- --
08/27/2020 Q2 -- -- -$0.30 -- --
03/31/2020 Q1 -- -- -$0.28 -- --
12/31/2019 Q4 -- -- -$0.27 -- --
09/30/2019 Q3 -- -- -$0.22 -- --
06/30/2019 Q2 -- -- -$0.19 -- --
03/31/2019 Q1 -- -- -$0.16 -- --

Relay Therapeutics, Inc. Earnings Questions

  • How Much did Relay Therapeutics, Inc. Generate in Revenue Last Quarter?

    Relay Therapeutics, Inc. reported $7M worth of top line sales in its most recent quarter.

  • Did Relay Therapeutics, Inc. Beat Earnings Last Quarter?

    Relay Therapeutics, Inc. announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.40 per share.

  • Is Relay Therapeutics, Inc. Profitable?

    Relay Therapeutics, Inc. reported $6.4M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Relay Therapeutics, Inc. EPS Next Year?

    Relay Therapeutics, Inc.'s earnings are forecast to decrease from -$1.61 per share to -$1.74 per share next year representing a decrease of -2.66%.

  • When is Relay Therapeutics, Inc.'s Earnings Date?

    Relay Therapeutics, Inc.'s next earnings date is May 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 27x

Alerts

Buy
51
AAOI alert for Apr 3

Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.

Buy
59
SBAC alert for Apr 3

SBA Communications Corp. [SBAC] is up 18.96% over the past day.

Buy
55
VSAT alert for Apr 3

ViaSat, Inc. [VSAT] is up 18.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock